Nanoparticles target distinct dendritic cell populations according to their size.
The efficiency of a vaccine largely depends on the appropriate targeting of the innate immune system, mainly through prolonged delivery of antigens and immunomodulatory substances to professional antigen-presenting cells in the lymphoid environment. Particulate antigens, such as virus-like particles...
Päätekijät: | Manolova, V, Flace, A, Bauer, M, Schwarz, K, Saudan, P, Bachmann, M |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2008
|
Samankaltaisia teoksia
-
Nanoparticles target distinct dendritic cell populations according to their size
Tekijä: Manolova, V, et al.
Julkaistu: (2007) -
Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.
Tekijä: Keller, SA, et al.
Julkaistu: (2010) -
Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines.
Tekijä: Gomes, A, et al.
Julkaistu: (2017) -
Cytokine production by peripheral blood cells following therapy with a combined vaccine of allergen and QbG10
Tekijä: Manolova, V, et al.
Julkaistu: (2008) -
Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation.
Tekijä: Keller, SA, et al.
Julkaistu: (2010)